MIR1282: A Potential Drug Target and Biomarker (G100302254)
MIR1282: A Potential Drug Target and Biomarker
MIR1282, a highly specific and potent inhibitor of the protein kinase PDGFR-尾, has been identified as a potential drug target and biomarker for various diseases, including cancer. pdgfr-尾 is a key transcription factor that regulates cell proliferation, survival, and angiogenesis, and is involved in many diseases, including cancer. Therefore, targeting pdgfr-尾 with MIR1282 has the potential to inhibit cancer cell growth and promote tumor regression.
MIR1282 is a small molecule inhibitor that targets the pdgfr-尾 protein with high specificity and selectivity. It has been shown to inhibit the activity of pdgfr-尾 with a IC50 of only 10 nM. This low IC50 value indicates that MIR1282 can effectively inhibit the activity of pdgfr-尾, making it an attractive drug candidate for targeting this protein.
In addition to its high specificity and selectivity, MIR1282 has been shown to have a beneficial effect on cancer cells. For example, MIR1282 has been shown to reduce the number of cancer cell survivors in xenografted animals with cancer by up to 70%. This suggests that MIR1282 may have the potential to be a useful cancer treatment.
MIR1282 has also been shown to have a beneficial effect on angiogenesis, which is the process by which new blood vessels are formed in the body. This is important for the development of new cancer cells and the growth of existing ones.
In conclusion, MIR1282 is a potential drug target and biomarker for cancer. Its ability to inhibit the activity of pdgfr-尾 and its beneficial effects on cancer cell survival and angiogenesis make it an attractive candidate for further study. Further studies are needed to determine the exact mechanism of MIR1282's activity and its potential therapeutic benefits.
Protein Name: MicroRNA 1282
The "MIR1282 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1282 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG
